Brief: Gland Pharma Q2 Consol Net Profit 1.64 Billion Rupees
Nov 4 (Reuters) - Gland Pharma Ltd GLAD.NS :
* GLAND PHARMA Q2 CONSOL NET PROFIT 1.64 BILLION RUPEES;
IBES EST.
1.6 BILLION RUPEES
* GLAND PHARMA Q2 CONSOL REVENUE FROM OPERATIONS 14.06
BILLION
RUPEES; IBES EST. 14.2 BILLION RUPEES
Source text: ID:
Further company coverage: GLAD.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Gland Pharma
See all newsIndia Stocks: Indian shares open higher as Fed-hike fears, oil prices ease; financials lead
India Stocks: Indian shares poised to rebound as Fed-hike fears, oil prices ease
Brief: Gland Pharma Approves $21 Million Investment In Gland Pharma Usa
Brief: Fosun Pharma Says Unit Sold Gland Pharma Shares for $294 Mln
India's Gland Pharma gains on successful completion of US FDA probe at Visakhapatnam plant